Clinical trial
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
NCT00584090 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
- Lead sponsor
- University of South Florida
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- November 30, 2007
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease, urinary incontinence